Dark
Light
Today: May 15, 2024
January 12, 2024
1 min read

Neocis Secures $20M Boost, Unleashing New Heights with Funding

TLDR:

  • Neocis, a company specializing in robot-assisted dental implant surgery, has raised $20 million in funding.
  • The funding round was led by Mirae Asset Capital/Mirae Asset Venture Investment and NVentures, the venture capital arm of NVIDIA.
  • Neocis plans to use the funds to expand its operations and reach in the dental implant surgery market.

Miami-based company Neocis has secured $20 million in funding for its robot-assisted dental implant surgery technology. The investment round was led by Mirae Asset Capital/Mirae Asset Venture Investment and NVentures, the venture capital arm of NVIDIA. The company plans to use the funds to expand its operations and business reach.

Neocis is the manufacturer and marketer of Yomi®, a robotic surgical system for dentistry that has been cleared by the US Food and Drug Administration (FDA). The Yomi platform has received a total of 16 FDA 510(k) clearances and assists clinicians during all phases of implant placement, providing streamlined digital planning and haptic guidance of surgical instrumentation for precise and efficient treatment. According to Neocis, more than 40,000 implants have been placed with robotic assistance, with approximately one dental implant being placed every six minutes using the Yomi system.

With this new funding, Neocis aims to expand its operations and business presence in the dental implant surgery market. The company has already gained significant traction and success with its Yomi system, and the investment will allow it to continue advancing its technology and reaching more clinicians and patients in need of dental implant surgery.

This funding round highlights the growing interest and investment in robotic-assisted surgical technologies, particularly in the field of dentistry. As advancements in robotics and artificial intelligence continue to revolutionize the healthcare industry, companies like Neocis are well-positioned to capitalize on the opportunities and provide innovative solutions to improve patient outcomes and enhance the capabilities of clinicians.

Previous Story

Finoa Secures $15M to Fuel Growth

Next Story

Unlocking Millionaire Secrets with Arlan Hamilton’s Proven Blueprint

Latest from Blog

Norrsken Unleashes €320M for Impact Entrepreneurs

TLDR: Norrsken VC has closed a €320m round to support “impact entrepreneurs”. The fund has strict criteria linked to UN Sustainable Development Goals and complies with the EU’s Sustainable Financial Disclosures regulation.
Go toTop